Fentanyl and Metabolite - Confirmation/Quantitation - Urine
0092570
 
Ordering Recommendation
Mnemonic
CDCO FENU
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Tue, Thu, Sat
Reported
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Random urine.  
Specimen Preparation
Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Room temperature.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
 
Stability
Ambient: 1 month; Refrigerated: 1 month; Frozen: 9 months  
Reference Interval
By report
Interpretive Data
Methodology: LC-MS/MS

Drugs covered: Fentanyl and norfentanyl

Positive cutoff: 1.0 ng/mL

For medical purposes only; not valid for forensic use.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

See Compliance Statement B: www.aruplab.com/CS
Note
CPT Code(s)
83925
Components
Component Test Code*Component Chart Name
2005886Fentanyl, Urine
2005887Norfentanyl, Urine
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Actiq
  • Duragesic
  • Durogesic
  • fentanyl and norfentanyl urine concentrations
  • Fentanyl, Quantitative, with medMATCH, Urine
  • Fentora
  • Innovar
  • Instanyl
  • Ionsys
  • Onsolis
  • Sublimaze